Evidence map›Paper›PMID 32435500›Full record

ArticleJournal of pharmaceutical policy and practice2020

A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19.

Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik, Zaheer-Ud-Din Babar

Abstract readEditorial
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2021
    Article
  7. Article
  8. Saudi Arabia, pharmacists and COVID-19 pandemic.Journal of pharmaceutical policy and practice · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadia Bukhari1School of Pharmacy, University College London, London, WC1N 1AX UK.
Mehr Manzoor2Department of Health Policy and Management, Tulane University, New Orleans, LA USA.
Huma Rasheed3Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Bismah Nayyer4Department of Population Health Sciences, Faculty of life Sciences & Medicine, King's College London, London, SE1 1UL UK.
Madeeha Malik5Hamdard University, Institute of Pharmaceutical Sciences, Islamabad, Pakistan.
Zaheer-Ud-Din Babar6Department of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This is a major challenge to global health policy. Gender diversity and inclusion within the pharmaceutical workforce is integral to optimal patient care. Women continue to be underrepresented in senior and leadership positions within pharmacy, despite outnumbering the men in the global pharmacy workforce. This commentary highlights the need towards gender equity and discusses the several key initiatives that are building momentum and making substantial progress towards this agenda in the pharmaceutical workforce.

Identifiers

PMID32435500
PMCPMC7225402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.